SARS-CoV-2-IN-73

• UNSPSC Description:

  SARS-CoV-2-IN-73 (compound 4) is a SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) blocker[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-in-73.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C=CN1[C@@H]2O[C@H](CNC(C3=C(O)C=C(O)C=C3O)=O)[C@@H](O)[C@]2(F)C)NC1=O

• Molecular Weight:

  411.34

• References & Citations:

  [1]Abdulwahed Alrehaily, et al. Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Sci Rep. 2023 Dec 27;13(1):23080.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported